Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemical and biological diversity of new natural products from marine sponges: a review (2009-2018). | Mar Life Sci Technol | 2022 | 37073163 | PubTator, text mining | PubMed |
| New species and records of Neomassaria, Oxydothis and Roussoella (Pezizomycotina, Ascomycota) associated with palm and bamboo from China. | MycoKeys | 2022 | 36761913 | PubTator, text mining | PubMed |
| Targeting senescent cells for a healthier longevity: the roadmap for an era of global aging. | Life Med | 2022 | 36699942 | PubTator, text mining | PubMed |
| Clinical impact of exome sequencing in the setting of a general pediatric ward for hospitalized children with suspected genetic disorders. | Front Genet | 2022 | 36699461 | PubTator, text mining | PubMed |
| Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance. | Front Genet | 2022 | 36685962 | PubTator, text mining | PubMed |
| High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration. | Front Genet | 2022 | 36685833 | PubTator, text mining | PubMed |
| Unraveling the links between neurodegeneration and Epstein-Barr virus-mediated cell cycle dysregulation. | Curr Res Neurobiol | 2022 | 36685766 | PubTator, text mining | PubMed |
| Characterizing (un)binding mechanism of USP7 inhibitors to unravel the cause of enhanced binding potencies at allosteric checkpoint. | Protein Sci | 2022 | 36629250 | PubTator, text mining | PubMed |
| Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics. | Front Immunol | 2022 | 36618350 | PubTator, text mining | PubMed |
| The Role of Deubiquitinating Enzyme in Head and Neck Squamous Cell Carcinoma. | Int J Mol Sci | 2022 | 36613989 | PubTator, text mining | PubMed |
Lysophosphatidic acid suppresses apoptosis of high-grade serous ovarian cancer cells by inducing autophagy activity and promotes cell-cycle progression via EGFR-PI3K/Aurora-AThr288-geminin dual signaling pathways. | Front Pharmacol | 2022 | 36601056 | PubTator, text mining | PubMed |
| Mesangial cell: A hub in lupus nephritis. | Front Immunol | 2022 | 36591251 | PubTator, text mining | PubMed |
| nuPRISM: Microfluidic Genome-Wide Phenotypic Screening Platform for Cellular Nuclei. | ACS Cent Sci | 2022 | 36589880 | PubTator, text mining | PubMed |
| Copy number variation analysis in 189 Romanian patients with global developmental delay/intellectual disability. | Ital J Pediatr | 2022 | 36585697 | PubTator, text mining | PubMed |
| USP13 regulates HMGB1 stability and secretion through its deubiquitinase activity. | Mol Med | 2022 | 36585612 | PubTator, text mining | PubMed |
| Editorial: Host immune evasion by Mycobacterium tuberculosis: Current updates. | Front Immunol | 2022 | 36582236 | PubTator, text mining | PubMed |
| The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis. | Front Cell Dev Biol | 2022 | 36578788 | PubTator, text mining | PubMed |
| Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners. | Chin Med J (Engl) | 2022 | 36574218 | PubTator, text mining | PubMed |
| Identification of Kv4.2 protein complex and modifications by tandem affinity purification-mass spectrometry in primary neurons. | Front Cell Neurosci | 2022 | 36568885 | PubTator, text mining | PubMed |
| EBV Association with Lymphomas and Carcinomas in the Oral Compartment. | Viruses | 2022 | 36560704 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=42